Board of Directors

Donald Almeida was the vice chairman for PwC. In this role, he was responsible for PwC’s global clients, markets, and industries. Almeida also was client service vice chairman for the U.S. firm and managing partner for several U.S. industry groups, including technology, infocom, and entertainment and media. In addition to these management roles, he served

Caleb has nearly 25 years of operating, startup, and financing experience in life science and healthcare companies. He plays an instrumental role in sourcing and structuring deals and works closely with portfolio companies to form strategic partnerships and to develop commercialization and marketing strategies. He currently (or formerly) represents Excel as a Board Director or

Dan Garrett serves on the Board of Directors of the eHealth Initiative. He recently served as PwC’s Technology Consulting practice Leader in the US & Trifecta regions (US, China/HK, and Japan). Dan worked as US leader of the Health Industries IT (HIT) practice, global Health Industries Analytics Lead, with responsibility for coordinating the practice across the

Dave Stevenson is Managing Director of Merck Global Health Innovation (GHI) Fund. Dave brings over 20 years of healthcare strategy and innovation expertise to the GHI team. In addition, Dave also brings a strong operational focus to accelerating value realization for portfolio companies. Prior to joining the Global Health Innovation Fund, Dave has been a

David Kim is the CEO of DigiTx Partners, bringing both business and clinical expertise to venture capital with an extensive background practicing medicine and building healthcare software companies. Most recently, Dr. Kim served as the COO of Lumiata, a venture-backed predictive analytics company positioned at the intersection of data science and medical science. Prior to

Michael is the Head of Samsung Ventures for Eastern North America and a Managing Director.  Michael joined Samsung in 2008 as part of the Global Strategy Group in the Chairman’s Office. Michael then joined Samsung Ventures in 2009 transferred from Seoul to Silicon Valley in 2013, and moved to Boston in 2019. Investments include Novaled

Chihiro is Investment Director, Rx+ Business Accelerator, Astellas Venture Management, and is actively seeking attractive opportunities to create new business in non-pharma field (Rx+). With this role, she has been working closely with DigiTx Partners for more than 2 years and has gained insight in digital health space. She has 15 years of experience in

Skip Fleshman has been at Asset Management Ventures (“AMV”) since 2002 and is actively investing in companies that focus on digital health, mobile and data analytics.Skip was an officer in the United States Air Force where he first served as a fighter pilot flying the F-16. He flew 37 combat missions during Operation Desert Storm